We have previously demonstrated, for example, the use of low-dose irradiation to reverse immune desertification combined with immune checkpoint blockade, CD40 agonist antibody, and cyclophosphamide to reprogram endogenous adaptive and innate immunity for improved control of ovarian cancer (ID8).38 This evidence concerns the gene CD40 and ovarian carcinoma.